Position in JNJ
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$27,959,303
-$2,190,659 QoQ
Shares Held
110,089
-10.7% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.80%
of 13F equity value
Holder Rank
#620
of 4,676 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Fisher Funds Management LTD holds $113,929,881 across 7 Drug Manufacturers - General names. JNJ ranks #1 (24.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
110,089 | $27,959,303 | |
| 2 | ABBV |
AbbVie Inc.
|
99,740 | $25,098,573 | |
| 3 | MRK |
Merck & Co., Inc.
|
151,132 | $19,420,462 | |
| 4 | LLY |
ELI LILLY & Co
|
14,451 | $17,332,964 | |
| 5 | AMGN |
Amgen Inc
|
24,245 | $8,779,599 | |
| 6 | PFE |
Pfizer Inc
|
324,451 | $7,812,780 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
59,571 | $7,526,200 |
All Filings in JNJ
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $27,959,303 | 110,089 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $30,149,962 | 123,343 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $32,295,168 | 156,053 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $28,935,347 | 156,053 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $23,837,095 | 156,053 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $28,755,329 | 173,392 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $25,075,951 | 173,392 | Shares | Sole | 2025-02-04 | |
| No filing history on record for this holder in this stock. | ||||||